Simulations Plus (FRA:SD3) PEG Ratio: N/A (As of Jul. 05, 2026)


FRA:SD3 Simulations Plus Inc FRA:SD3
67 GF Score
Price €15.80
GF Value €32.93
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Simulations Plus's PE Ratio without NRI is 20.20. Simulations Plus's 5-Year EBITDA growth rate is -3.40%. Therefore, Simulations Plus's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Simulations Plus's PEG Ratio or its related term are showing as below:


During the past 13 years, Simulations Plus's highest PEG Ratio was 87.04. The lowest was 1.50. And the median was 4.44.


FRA:SD3's PEG Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.41
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Simulations Plus  (FRA:SD3) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Simulations Plus PEG Ratio Related Terms


Simulations Plus PEG Ratio Historical Data

* Premium members only.

The historical data trend for Simulations Plus's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus PEG Ratio Chart

Simulations Plus Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.28 17.58 0.00 0.00 0.00

Simulations Plus Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:SD3 vs TBRG, CARL, NRC: PEG Ratio Comparison

For the Health Information Services subindustry, Simulations Plus's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus PEG Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Simulations Plus's PEG Ratio falls into.


FRA:SD3
67GF Score
Simulations Plus Inc FRA:SD3
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Simulations Plus's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=20.204603580563/-3.40
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Simulations Plus (FRA:SD3) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of €15.80 is trading 52% below its estimated GF Value™ of €32.93. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for FRA:SD3:

  • PEG Ratio: N/A
  • GF Value™: €32.93 vs. price of €15.80 (52% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Simulations Plus Business Description

Other Exchanges SLP:USA
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
67GF Score

Get the complete analysis for FRA:SD3

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.80
Price
€32.93
GF Value